CCK-8 assay suggested that GBM cell viability was significantly reduced through sh-DLEU1#3 transfection (P<0.01), but pcDNA-SP1 (P<0.05) or miR-4429 inhibitor (P<0.05) countervailed the reduction (Figure 5A). Here, SP1 is linked to glioblastoma.